NEW YORK, NY / ACCESS Newswire / March 26, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Alarum Technologies Ltd. (NASDAQ:ALAR) between March 14, 2024 and August 26, 2024, both dates inclusive (the "Class Period"), of the important April 15, 2025 lead plaintiff deadline.

The company says the new "Qwen2.5-Omni-7B" is a multimodal model that can process text, images, audio, and videos, while generating real-time text and natural speech responses. Amid China's AI fervor accelerated by DeepSeek, Alibaba and other generative AI competitors have been releasing new, cost-effective models and products at an unprecedented pace.

TORONTO--(BUSINESS WIRE)---- $CIX #CIFinancial--CI Financial announces a debenture offering with a principal amount of $500 million to refinance existing indebtedness.

Petco Health and Wellness Company, Inc. (NASDAQ:WOOF ) Q4 2024 Earnings Conference Call March 26, 2025 4:30 PM ET Company Participants Tina Romani - Head of IR & Treasury Joel Anderson - CEO Sabrina Simmons - CFO Conference Call Participants Steve Forbes - Guggenheim Steven Zaccone - Citi Michael Lasser - UBS Oliver Wintermantel - Evercore Simeon Gutman - Morgan Stanley David Lantz - Wells Fargo Peter Benedict - Baird Kendall Toscano - Bank of America Seth Basham - Wedbush Securities Chris Bottiglieri - BNP Paribas Operator Good afternoon, and welcome to the Petco Fourth Quarter and Full Year 2024 …

NEW YORK, NY / ACCESS Newswire / March 26, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Viatris Inc. ("Viatris Inc.") (NASDAQ:VTRS) concerning possible violations of federal securities laws. Viatris issued a press release on February 27, 2025, reporting its fourth quarter and full year 2024 financial results, which missed consensus estimates with respect to key metrics.

NEW YORK, NY / ACCESS Newswire / March 26, 2025 / If you suffered a loss on your Walgreens Boots Alliance, Inc. (NASDAQ:WBA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/walgreens-boots-alliance-inc-lawsuit-submission-form-2?prid=139022&wire=1 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / March 26, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Civitas Resources, Inc. (NYSE:CIVI) resulting from allegations that Civitas Resources may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Civitas Resources securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

NEW YORK, NY / ACCESS Newswire / March 26, 2025 / If you suffered a loss on your AppLovin Corporation (NASDAQ:APP) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applovin-corporation-lawsuit-submission-form?prid=139023&wire=1 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / March 26, 2025 / If you suffered a loss on your TransMedics Group, Inc. (NASDAQ:TMDX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/transmedics-group-inc-lawsuit-submission-form-2?prid=139024&wire=1 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / March 26, 2025 / If you suffered a loss on your Geron Corporation (NASDAQ:GERN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/geron-corporation-lawsuit-submission-form?prid=139026&wire=1 or contact Joseph E. Levi, Esq.

PALO ALTO, Calif., March 26, 2025 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex” or “Company”), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain and, following the formation of its proposed joint venture with IPMC Company, in neurodegenerative and cardiometabolic disease, reiterates that it has appealed a lower court decision to the U.S. Court of Appeals for the Federal Circuit in Washington, DC and will continue to vigorously pursue its infringement action on appeal against Aveva Drug Delivery Systems, Inc. (“Aveva”).

NEW YORK, March 26, 2025 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that Ryoncil® (remestemcel-L) the first mesenchymal stromal cell (MSC) therapy approved by U.S. Food and Drug Administration (FDA) for any indication, is now available for purchase in the United States.

QUEBEC CITY, Canada, March 26, 2025 (GLOBE NEWSWIRE) -- LeddarTech® Holdings Inc. (“LeddarTech” or the “Corporation”) (Nasdaq: LDTC), an automotive software company that provides patented disruptive AI-powered low-level sensor fusion and perception software technology, LeddarVision™, announces the voting results of its annual general and special meeting of shareholders held on March 26, 2025 (the “Meeting”). Shareholders voted on various proposals and elected directors to the board.

Paychex President and CEO John Gibson joins 'Mad Money' host Jim Cramer to talk quarterly results, the state of small businesses, quarterly revenue and more.

Verint Systems Inc. (NASDAQ:VRNT ) Q4 2025 Earnings Conference Call March 26, 2025 4:30 PM ET Company Participants Matthew Frankel - CFA, Investor Relations Dan Bodner - CEO Grant Highlander - CFO Conference Call Participants Joshua Reilly - Needham Peter Levine - Evercore Timothy Horan - Oppenheimer Shaul Eyal - TD Cowen Operator Good day, and thank you for standing by. Welcome to Verint Systems Inc. fourth -- I'm sorry, Q4 2025 Earnings Conference Call.

Gold edged higher in the early Asian session, supported by prospects of rising investor demand.

The measure, which is intended to bring car factories to the United States, could significantly raise prices for consumers.

DURECT Corporation (NASDAQ:DRRX ) Q4 2024 Earnings Conference Call March 26, 2025 4:30 PM ET Company Participants Tim Papp - Chief Financial Officer Jim Brown - Co-Founder, Chief Executive Officer, President, Director Norman Sussman - Chief Medical Officer WeiQi Lin - Executive Vice President, Research & Development and Principal Scientist Conference Call Participants François Brisebois - Oppenheimer & Company Karl Burns - Northland Capital Markets Thomas Yip - H.C. Wainwright Operator Greetings and welcome to the DURECT Corporation Fourth Quarter and Full-Year 2024 Earnings Conference Call.

U.S. President Donald Trump on Wednesday unveiled a 25% tariff on imported cars and light trucks starting next week, widening the upon regaining the White House this year in a move auto industry experts expect will drive up prices and stymie production.

Note: The following is an excerpt from this week's Earnings Trends report. You can access the full report that contains detailed historical actual and estimates for the current and following periods, please click here>>>